Showing 1 - 8 results of 8 for search 'Kaidre Bendjama', query time: 0.03s
Refine Results
-
1
Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer by Kaïdre Bendjama, Eric Quemeneur
Published 2017-09-01
Article -
2
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC by Caroline Tosch, Bérangère Bastien, Luc Barraud, Benoit Grellier, Virginie Nourtier, Murielle Gantzer, Jean Marc Limacher, Eric Quemeneur, Kaïdre Bendjama, Xavier Préville
Published 2017-09-01
Article -
3
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and M... by Christelle Remy-Ziller, Christine Thioudellet, Julie Hortelano, Murielle Gantzer, Virginie Nourtier, Marie-Christine Claudepierre, Benoit Sansas, Xavier Préville, Kaïdre Bendjama, Eric Quemeneur, Karola Rittner
Published 2018-01-01
Article -
4
Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients by Emma J. West, Karen J. Scott, Emma Tidswell, Kaidre Bendjama, Nicolas Stojkowitz, Monika Lusky, Marta Kurzawa, Raj Prasad, Giles Toogood, Christy Ralph, D. Alan Anthoney, Alan A. Melcher, Fiona J. Collinson, Adel Samson
Published 2022-04-01
Article -
5
Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC by Adrian von Witzleben, Adrian von Witzleben, Eve Currall, Oliver Wood, Lindsey Chudley, Oluyemisi Akinyegun, Jaya Thomas, Kaïdre Bendjama, Gareth J. Thomas, Gareth J. Thomas, Peter S. Friedmann, Emma V. King, Emma V. King, Simon Laban, Christian H. Ottensmeier, Christian H. Ottensmeier
Published 2021-01-01
Article -
6
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial by Fabien Zoulim, Claire Fournier, François Habersetzer, Martin Sprinzl, Stanislas Pol, Carla S Coffin, Vincent Leroy, Mang Ma, Heiner Wedemeyer, Ansgar W Lohse, Robert Thimme, Karine Lugardon, Perrine Martin, Bérangère Bastien, Benoit Sansas, Nathalie Adda, Celine Halluard, Kaïdre Bendjama, Maud Brandely, Geneviève Inchauspé
Published 2020-02-01
Article -
7
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer by Chuan Wang, Kaïdre Bendjama, Stephen Schoenberger, Oliver Wood, Gareth Thomas, Pandurangan Vijayanand, Tilman Sanchez-Elsner, Nathalie Silvestre, Natalia Savelyeva, Christian Ottensmeier, Katy McCann, Adrian von Witzleben, Jaya Thomas, Divya Singh, Konstantinos Boukas, Finn Cilius Nielsen, Jason Greenbaum, Bjoern Peters
Published 2022-03-01
Article -
8
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination by Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie‐Christine Claudepierre, Doris Schmitt, Christelle Remy‐Ziller, Chantal Hoffmann, Marine Ricordel, Virginie Nourtier, Isabelle Farine, Laurence Laruelle, Julie Hortelano, Clementine Spring‐Giusti, Christine Sedlik, Christophe Le Tourneau, Caroline Hoffmann, Nathalie Silvestre, Philippe Erbs, Kaidre Bendjama, Christine Thioudellet, Eric Quemeneur, Eliane Piaggio, Karola Rittner
Published 2022-01-01
Article